829 related articles for article (PubMed ID: 12605362)
21. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
22. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival.
Chen CA; Cheng WF; Lee CN; Wei LH; Chu JS; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Feb; 80(2):207-12. PubMed ID: 11161861
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
24. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
26. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.
Obermair A; Kohlberger P; Bancher-Todesca D; Tempfer C; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Breitenecker G; Gitsch G
Gynecol Oncol; 1996 Nov; 63(2):204-9. PubMed ID: 8910628
[TBL] [Abstract][Full Text] [Related]
27. Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression.
Hansel DE; Rahman A; Hermans J; de Krijger RR; Ashfaq R; Yeo CJ; Cameron JL; Maitra A
Mod Pathol; 2003 Jul; 16(7):652-9. PubMed ID: 12861060
[TBL] [Abstract][Full Text] [Related]
28. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
Qi SY
Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
[TBL] [Abstract][Full Text] [Related]
29. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
31. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
32. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
Gaumann AK; Schermutzki G; Mentzel T; Kirkpatrick CJ; Kriegsmann JB; Konerding MA
Oncol Rep; 2008 Feb; 19(2):309-18. PubMed ID: 18202776
[TBL] [Abstract][Full Text] [Related]
33. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study.
Ogata Y; Fujita H; Yamana H; Sueyoshi S; Shirouzu K
World J Surg; 2003 May; 27(5):584-9. PubMed ID: 12715228
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
35. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
[TBL] [Abstract][Full Text] [Related]
37. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M
Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
Ravindranath N; Wion D; Brachet P; Djakiew D
J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
[TBL] [Abstract][Full Text] [Related]
40. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
Borre M; Nerstrøm B; Overgaard J
Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
